{"organizations": [], "uuid": "1dc3c03a1cd6883e7832e6a2958d9f1016ae52fb", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180306.html", "section_title": "Archive News &amp; Video for Tuesday, 06 Mar 2018 | Reuters.com", "url": "https://www.reuters.com/article/brief-ptc-therapeutics-q4-revenue-780-mi/brief-ptc-therapeutics-q4-revenue-78-0-million-idUSFWN1QO0SM", "country": "US", "domain_rank": 408, "title": "BRIEF-PTC Therapeutics Q4 Revenue $78.0 Million", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.874, "site_type": "news", "published": "2018-03-07T05:18:00.000+02:00", "replies_count": 0, "uuid": "1dc3c03a1cd6883e7832e6a2958d9f1016ae52fb"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/brief-ptc-therapeutics-q4-revenue-780-mi/brief-ptc-therapeutics-q4-revenue-78-0-million-idUSFWN1QO0SM", "ord_in_thread": 0, "title": "BRIEF-PTC Therapeutics Q4 Revenue $78.0 Million", "locations": [], "entities": {"persons": [], "locations": [], "organizations": [{"name": "ptc therapeutics inc", "sentiment": "negative"}, {"name": "reuters", "sentiment": "negative"}, {"name": "thomson reuters", "sentiment": "none"}, {"name": "eikon", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "March 6 (Reuters) - PTC Therapeutics Inc:\n* ‍TOTAL REVENUES FOR Q4 OF 2017 WERE $78.0 MILLION COMPARED TO $25.2 MILLION IN Q4 OF 2016​\n* SEES ‍FULL YEAR 2018 NET PRODUCT REVENUES TO BE BETWEEN $260 AND $295 MILLION​\n* ‍PTC ANTICIPATES TRANSLARNA NET PRODUCT REVENUE FOR FULL YEAR 2018 TO BE BETWEEN $170 AND $185 MILLION​\n* ‍PTC PROJECTS A 5-YEAR (DECEMBER 31, 2022) COMPOUND ANNUAL GROWTH RATE OF 15% FOR NET PRODUCT REVENUES​\n* ‍PTC ANTICIPATES EMFLAZA NET PRODUCT REVENUE FOR FULL YEAR 2018 TO BE BETWEEN $90 AND $110 MILLION​\n* QTRLY ‍SHR $ 0.03​ * Q4 REVENUE VIEW $74.4 MILLION — THOMSON REUTERS I/B/E/S Source text for Eikon: Further company coverage:\n ", "external_links": ["http://thomsonreuters.com/en/about-us/trust-principles.html"], "published": "2018-03-07T05:18:00.000+02:00", "crawled": "2018-03-07T19:46:31.007+02:00", "highlightTitle": ""}